The Evidence Based Rheumatology Podcast
Health & Fitness:Medicine
At ACR23 I had a twitter-disagreement about steroid tapers from PEXIVAS with Mike Walsh, the lead author on the PEXIVAS trial. He kindly agreed to join me for a moderated discussion. Loved hearing his perspective and have to admit he pulled me closer to his practice... but not all the way there. Longer podcast than usual but I prefer to release audio uncut and this took as long as it needed! Hoping y'all enjoy.
Articles referenced during the podcast:
PEXIVAS: https://www.nejm.org/doi/full/10.1056/nejmoa1803537
PEXIVAS DAH Subset: https://www.atsjournals.org/doi/10.1164/rccm.202308-1426OC
Fussner Abstract: https://acrabstracts.org/abstract/characteristics-and-outcomes-of-participants-with-and-without-diffuse-alveolar-hemorrhage-in-the-plasma-exchange-and-glucocorticoids-in-severe-anca-associated-vasculitis-pexivas-trial/
Walsh Meta Analysis: https://pubmed.ncbi.nlm.nih.gov/35217545/
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson
E109: Abatacept for Pre-RA - the ARIAA Study
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd
E107: Fragility of SLE Randomized Controlled Trials
E106: GCA/PMR with Bhaskar Dasgupta
E105: Autoimmunity Post COVID-19?
E104: Sarilumab for PMR - The SAPHYR Study
E103: Len Calabrese on Monoclonal Antibodies for COVID-19
E102: Unintentional Unblinding in Rheumatic Disease Trials
E101: Pred v Colchicine for CPPD: COLCHICORT
E100: ADVOCATE Health Related Quality of Life
E99: Hospital Problems
E98: Key Opinion Leaders & ILD Guidelines
E97: Does allopurinol reduce CVD? The ALLHEART Study
E96: Long COVID - Where to After Norway?
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
E94: Steroids and Psoriasis Flares
E93: Azathioprine is the Worst
E92: Are muscle symptoms from statins imaginary?
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive